PANADOL ACTIFAST SOLUBLE

Adults, the elderly, and children aged 16 years and over: 1 -2 tablets in at least half a tumbler of water, up to 4 times daily as required.

Children:

Aged 10-15 years: 1 tablet dissolved in water up to 4 times daily. Not recommended for children under the age of 10 years. Children should not be given paracetamol for more than 3 days without consulting a doctor. Doses of paracetamol should not be given more frequently than every 4 hours, and not more than 4 doses should be given in any 24 hour period.

Oral administration only.

Adverse events of paracetamol from historical clinical trial data are both infrequent and from small patient exposure. Accordingly, events reported from extensive post-marketing experience at therapeutic/labelled dose and considered attributable are tabulated below by system class and frequency.

The following convention has been utilised for the classification of the undesirable effects: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1000 to <1/100), rare (≥1/10,000 to <1/1000) and very rare (<1/10,000), not known (cannot be estimated from available data).

Adverse event frequencies have been estimated from spontaneous reports received through post-marketing data. Post marketing data Body System Undesirable effect Frequecny Blood and lymphatic Thrombocytopenia Very rare system disorders Agranulocytosis Immune system disorders Anaphylaxis Cutaneous hypersensitivity reactions including, among others, skin rashes and angiodema.

4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients. ** There have been cases of bronchospasm with paracetamol, but these are more likely in asthmatics sensitive to aspirin or other NSAIDs.

Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store.

Contains paracetamol. Do not use with any other paracetamol-containing products. Underlying liver disease increases the risk or paracetamol related liver damage. Patients who have been diagnosed with liver or kidney impairment must seek medical advice before taking this medication.

Do not exceed the stated dose. Patients should be advised to consult their doctor if their headaches become persistent. Patients should be advised to consult a doctor if they suffer from non-serious arthritis and need to take painkillers every day.

Each soluble tablet contains 427 mg of sodium per tablet (854 mg of sodium per 2 tablet dose). To be taken into consideration by patients on a controlled sodium diet. 50 mg per tablet. Patients with rare hereditary problems of fructose intolerance should not take this medicine.

g. chronic alcoholism) who were treated with paracetamol at therapeutic dose for a prolonged period or a combination of paracetamol and flucloxacillin. If HAGMA due to pyroglutamic acidosis is suspected, prompt discontinuation of paracetamol and close monitoring is recommended.

The measurement of urinary 5-oxoproline may be useful to identify pyroglutamic acidosis as underlying cause of HAGMA in patients with multiple risk factors. If symptoms persist, medical advice must be sought. Keep out of the sight and reach of children.

Pack Label:

Talk to a doctor at once if you take too much of this medicine even if you feel well. Do not take anything else containing paracetamol while taking this medicine.

Patient Information Leaflet:

Talk to a doctor at once if you take too much of this medicine even if you feel well. This is because too much paracetamol can cause delayed, serious liver damage.

Hypersensitivity to paracetamol or any of the other constituents.